Biomedical, Clinical & Life Sciences

No Applicants // Limit: one postdoctoral applicant per lab

The Predoctoral Fellowship in Drug Discovery Targets and Pathways provides support for promising students in advanced stages of training and thesis research in drug discovery research.

Eligibility: 

• Applicants will have completed most of their pre-thesis requirements and be PhD candidates. 
• Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. 
• Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. 

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants   // Limit: one postdoctoral applicant per lab

The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease. 

Eligibility:

• Applicants must hold a PhD, PharmD, MD, before funding can begin.
• Applicants must be within their first five years of postdoctoral study at the time of award activation.

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants  // Limit: one postdoctoral applicant per lab

The Predoctoral Fellowship in Drug Delivery provides support for promising students in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility: 

• Applicants will have completed most of their pre-thesis requirements and be PhD candidates. 
• Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. 
• Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. 

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants // Limit: one postdoctoral applicant per lab

The Postdoctoral Fellowship in Drug Delivery supports individuals engaged in a multidisciplinary, collaborative research training program that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility:

• Applicants must hold a PhD, PharmD, MD, before funding can begin.
• Applicants must be within their first five years of postdoctoral study at the time of award activation.

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

Limit: 1 //  S. Radovick ( Health Sciences)

The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars in clinical and translational science who have made a commitment to independent research careers (i.e., tenure-track or equivalent faculty positions), and to facilitate their timely transition to more advanced support mechanisms, e.g., K08, K23, R01, R03, etc. Applicants must submit both a UM1 application to PAR-21-293: Clinical and Translational Science Award and a K12 application to this FOA.

This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

With this solicitation for the K12 application, a separate, companion FOA solicits applications for a required UM1 (PAR-21-293). A UM1 hub application without the required companion K12 application will not be reviewed. The required K12 application will only be awarded if the UM1 application is awarded. Initial and resubmission of K12 will be accepted concurrently or if the UM1 application is awarded.

The application must provide a specific plan describing the partnership between the UM1, the required K12 and any optional components. The applicant institution must be the UM1 applicant. The UM1 institution must have a strong and high-quality research program in the area(s) proposed under this K12 FOA and must have the requisite faculty, staff, potential scholars and facilities on site to conduct the proposed institutional program. In many cases, it is anticipated that the proposed program will complement other ongoing career development programs occurring at the applicant institution and that a substantial number of program faculty will have active research projects in which participating scholars may gain relevant experiences consistent with their research interests and goal.

The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program includes the provision of adequate staff, facilities, and educational resources that can contribute to the planned program.

The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI will be responsible for the selection and appointment of trainees to the approved research training program, and for the overall direction, management, administration, and evaluation of the program. The PD/PI will be expected to monitor and assess the program and submit all documents and reports as required. The PD/PI has responsibility for the day to day administration of the program and is responsible for appointing members of the Advisory Committee (when applicable), using their recommendations to determine the appropriate allotment of funds.

Only one K12 application will be awarded if the UM1 application is awarded. If the UM1 is awarded and the initial K12 is not, the K12 application may be resubmitted. If the UM1 (A0) application is not awarded, then the K12 (A0) will not be awarded.

NCATS solicits the submission of one set of companion applications. With this FOA for the K12 application, a separate, companion FOA seeks applications for a required UM1 (PAR-21-293: Clinical and Translational Science Award). The UM1 and initial K12 applications must be submitted concurrently; a K12 application without the required companion UM1 application will not be reviewed. The required K12 application will only be awarded if the UM1 application is awarded. 

Limit: 1 // S. Carvajal (Health Promotion Sciences /Arizona Prevention Research Center (AzPRC)).

Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP from the same institution are NOT permitted).

This Notice of Funding Opportunity (NOFO) will provide supplemental funding to the CDC Health Promotion and Disease Prevention Research Centers (RFA-DP-24-004) to conduct Special Interest Research Projects (SIP) to inform public health practice. Recipients will conduct high-quality applied health promotion and disease prevention research in real-world settings to identify, design, test, assess, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

Competition is limited to the 20 institutions approved for funding under CDC RFA-DP-24-004 as CDC Prevention Research Centers (PRCs). The institutions currently approved for funding are:
U48 DP006799 University of Arizona PI:  S. Carvajal

No Applicants // Limit: 1 // Tickets Available: 1 

 Multiple applications from an organization are not allowed. 

This notice announces the opportunity to apply for funding under the Maternal Health Training and Resource Center (MHTRC) program. The purpose of this program is to support MCHB’s maternal health recipients, with a primary focus on the State Maternal Health Innovation (State MHI) program, to improve maternal health and to respond to the needs of populations impacted by maternal mortality and severe maternal morbidity (SMM). The MHTRC will also provide limited support to MCHB’s maternal health recipients with the implementation of maternal health projects, innovations, and initiatives in their respective states, where funds are available.

The goals of the MHTRC are to improve maternal health by:

• Providing tailored technical assistance (TA), capacity-building assistance (CBA), and evaluation support services to recipients of MCHB’s maternal health programs to aid awardees in addressing the needs of maternal health for populations disproportionately impacted by maternal mortality and severe maternal morbidity (SMM).

• Establishing a national resource center that provides evidence-based strategies and guidance to improve maternal health, reduce maternal mortality and SMM, and advance health equity at the individual, interpersonal, community, and societal levels.

We estimate approximately $3,000,000 to be available annually to fund one recipient. You may apply for a ceiling amount of up to $3,000,000 annually (reflecting direct and indirect costs). The period of performance is September 30, 2024, through September 29, 2029 (5 years).

No Applicants   //  Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique entity identifier (UEI) or NIH IPF number) is allowed.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.

To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on:

• Courses for Skills Development

This R25 program will support the development and implementation of short courses to prepare nurse scientists, and scientists in aligned fields, to conduct firearm injury prevention research in support of the NINR Strategic Plan (https://www.ninr.nih.gov/aboutninr/ninr-mission-and-strategic-plan). Applications for courses that build on the existing knowledge, approaches, methods, and techniques related to injury prevention to advance research specifically in the area of firearm injury are encouraged. Proposed courses should include content related to inequities in firearm injuries (e.g., race, ethnicity, socioeconomic position, gender, geography, and their intersections) and research at the individual, community, institutional, and structural levels.

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Budgets are limited to $200,000 direct costs per year and need to reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is three (3) years

No Applicants // Limit: 1 // Tickets Available: 1 

The purpose of this notice of funding opportunity (NOFO) is to support enhanced surveillance and applied research for influenza virus or other respiratory infections in humans and animals in China. This support aims to better define the global risk and to build the evidence for prevention and control of novel and seasonal avian and non-avian seasonal influenza viruses and other respiratory diseases in China. The scope of research performed will include, but will not be limited to, activities such as estimating the burden and cost of illness for groups at high risk for severe disease; monitoring vaccine uptake and efficacy; promoting vaccine programs for groups at high risk for severe influenza complications; and conducting surveillance for detection and control of novel and seasonal influenza viruses and other respiratory pathogens. Research activities for the prevention and control of novel and seasonal influenza viruses and other respiratory pathogens and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission within China and potentially to other countries, including the United States. Continued monitoring, detection, and reporting of these influenza viruses and other respiratory pathogens in China will advance global health efforts. These activities will assist to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. This NOFO provides an opportunity to conduct research in these important areas.

No Applicants  // Limit: 1 // Tickets Available: 1 

These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future.

Grant Criteria and Eligibility:

• The probability of an advance in prevention, diagnosis or treatment for the near-term
• The novelty of the concept and strategy
• The clarity of presentation
• The overall plan for bringing the research findings to clinical application
• Experience, background, and qualifications of the investigators
• Adequacy of resources and environment (facilities, patients, etc.)
• PCRF only funds non-profit institutions and they must be located in the US.
• PCRF does not have citizenship requirements for our investigators. However, the Principal Investigator needs to be employed by a non-profit U.S. institution that has an affiliation with a hospital.
• Basic Science Research and Translational Grants require the applicant to be a PhD and/or MD.
• Emerging Investigator applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period.